logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

US Stock Market Update | Storage chip concept stocks collectively plummet, SanDisk (SNDK.US) falls over 11%

date
06/08/2026
According to the Zhitong Finance APP, on Thursday, storage chip concept stocks collectively plummeted. Western Digital (WDC.US) fell more than 18%, SanDisk (SNDK.US) dropped over 11%, SK Hynix (SKHY.US) declined over 7%, Seagate Technology (STX.US) decreased by more than 6%, and Micron Technology (MU.US) fell nearly 6%.
Latest
1 m ago
Yidun Electronics (603328.SH) plans to invest 2.979 billion yuan to construct an intelligent manufacturing project for high-end printed circuit boards.
3 m ago
After the U.S. Energy Information Administration announced that the increase in natural gas inventories met expectations, U.S. natural gas futures continued to decline, falling by 2.1%.
4 m ago
Yidun Electronics (603328.SH) plans to raise no more than 2 billion yuan through a private placement for a high-end printed circuit board intelligent manufacturing project.
4 m ago
US stock movement | Zai Ding Pharmaceutical (ZLAB.US) surged over 12% as Q2 product revenue increased by 11% quarter-on-quarter.
5 m ago
Yiteng Jiahe (06998): The first subject has been dosed in the Phase Ib/II clinical trial of GB268.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.